BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1662633)

  • 1. High and prolonged pulmonary tissue concentrations of azithromycin following a single oral dose.
    Morris DL; De Souza A; Jones JA; Morgan WE
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):859-61. PubMed ID: 1662633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration of azithromycin in human prostatic tissue.
    Foulds G; Madsen P; Cox C; Shepard R; Johnson R
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):868-71. PubMed ID: 1722460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azithromycin concentrations in sinus fluid and mucosa after oral administration.
    Karma P; Pukander J; Penttilä M
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):856-9. PubMed ID: 1662632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of azithromycin in human tonsillar tissue.
    Foulds G; Chan KH; Johnson JT; Shepard RM; Johnson RB
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):853-6. PubMed ID: 1662631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynaecological tissue levels of azithromycin.
    Krohn K
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):864-8. PubMed ID: 1662635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin levels in plasma and gastric tissue, juice and mucus.
    Harrison JD; Jones JA; Morris DL
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):862-4. PubMed ID: 1662634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalence of a high-performance liquid chromatographic assay and a bioassay of azithromycin in human serum samples.
    Riedel KD; Wildfeuer A; Laufen H; Zimmermann T
    J Chromatogr; 1992 May; 576(2):358-62. PubMed ID: 1328265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of dose regimens of azithromycin .
    Foulds G; Johnson RB
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():39-50. PubMed ID: 8396095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of azithromycin in lung tissue, bronchial washing, and plasma in patients given multiple oral doses of 500 and 1000 mg daily.
    Di Paolo A; Barbara C; Chella A; Angeletti CA; Del Tacca M
    Pharmacol Res; 2002 Dec; 46(6):545-50. PubMed ID: 12457629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azithromycin concentrations at the sites of pulmonary infection.
    Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
    Eur Respir J; 1990 Sep; 3(8):886-90. PubMed ID: 1963411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of azithromycin and their clinical significance.
    Lode H
    Eur J Clin Microbiol Infect Dis; 1991 Oct; 10(10):807-12. PubMed ID: 1662623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
    Cooper MA; Nye K; Andrews JM; Wise R
    J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
    Le Gros V; Farinotti R; Brion N; Regnard JF; Azorin J; Parrot AM; Chiche D
    Pathol Biol (Paris); 1992 May; 40(5):545-50. PubMed ID: 1495842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of azithromycin in pediatric patients after oral administration of multiple doses of suspension.
    Nahata MC; Koranyi KI; Gadgil SD; Hilligoss DM; Fouda HG; Gardner MJ
    Antimicrob Agents Chemother; 1993 Feb; 37(2):314-6. PubMed ID: 8383944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses.
    Olsen KM; San Pedro G; Gann LP; Gubbins PO; Halinski DM; Campbell GD
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2582-5. PubMed ID: 8913469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of azithromycin in serum, bronchial washings, alveolar macrophages and lung tissue following a single oral dose of extended or immediate release formulations of azithromycin.
    Lucchi M; Damle B; Fang A; de Caprariis PJ; Mussi A; Sanchez SP; Pasqualetti G; Del Tacca M
    J Antimicrob Chemother; 2008 Apr; 61(4):884-91. PubMed ID: 18252692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of azithromycin after single oral dosing of experimental animals.
    Davila D; Kolacny-Babić L; Plavsić F
    Biopharm Drug Dispos; 1991 Oct; 12(7):505-14. PubMed ID: 1657238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacokinetics of azithromycin in human serum and tissues.
    Foulds G; Shepard RM; Johnson RB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():73-82. PubMed ID: 2154441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the pharmacokinetics of three-day and five-day regimens of azithromycin in plasma and urine.
    Wildfeuer A; Laufen H; Leitold M; Zimmermann T
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():51-6. PubMed ID: 8396097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion of oral and intravenous 400 mg once-daily moxifloxacin into lung tissue at pharmacokinetic steady-state.
    Breilh D; Jougon J; Djabarouti S; Gordien JB; Xuereb F; Velly JF; Arvis P; Landreau V; Saux MC
    J Chemother; 2003 Dec; 15(6):558-62. PubMed ID: 14998080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.